Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and obesity.

HealthDay News — Most U.S. adults have not heard of cardiovascular-kidney-metabolic (CKM) syndrome, according to a survey released by the American Heart Association. The online survey included 4,007 U ...

Cardiovascular disease risk may be attributed to factors beyond changes in estrogen among women undergoing the menopause ...

A fully automated deep learning workflow for echocardiography in pulmonary arterial hypertension (PAH) is accurate and feasible.

Visceral fat and hepatic fat (HF) are associated with carotid atherosclerosis, according to a study published online.

Vaping-related disorder is rare in patients with chronic lung disease but is also associated with a much higher likelihood of mortality.

Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal pulmonary PFT results.

The FDA has expanded the approval of Winrevair to include treatment of adults with PAH WHO Group 1 to improve exercise capacity and WHO FC, and reduce the risk of clinical worsening events including ...

Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with ...

In patients with diabetes receiving isolated CABG, there are no significant differences in safety between MAG and SAG.

With or without large-scale urbanization, compact city design at the community level may improve stroke care provision and outcomes.

Phthalate exposure is associated with adverse effects on cardiovascular health in patients with chronic kidney disease (CKD).